Richard Murray
Directeur/Membre du Conseil chez Stellular Bio, Inc.
Postes actifs de Richard Murray
Sociétés | Poste | Début | Fin |
---|---|---|---|
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Directeur/Membre du Conseil | 04/06/2019 | - |
Historique de carrière de Richard Murray
Anciens postes connus de Richard Murray
Sociétés | Poste | Début | Fin |
---|---|---|---|
JOUNCE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/07/2014 | 03/05/2023 |
Directeur Général | 10/07/2014 | 31/03/2023 | |
President | 10/07/2014 | 31/03/2023 | |
MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2009 | 01/01/2014 |
PDL BIOPHARMA, INC. | Directeur/Membre du Conseil | 01/01/2007 | 05/09/2008 |
Directeur Technique/Scientifique/R&D | 01/04/2003 | 05/09/2008 | |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Directeur Technique/Scientifique/R&D | 01/04/2003 | 10/01/2006 |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Directeur Technique/Scientifique/R&D | 01/02/1998 | 01/04/2003 |
Fondateur | 01/02/1998 | 01/04/2003 | |
DNAX Research, Inc. | Directeur Technique/Scientifique/R&D | 01/01/1991 | 01/01/1998 |
Formation de Richard Murray
The University of North Carolina at Charlotte | Doctorate Degree |
University of Massachusetts | Undergraduate Degree |
The University of North Carolina at Chapel Hill | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 4 |
Director/Board Member | 3 |
Doctorate Degree | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Health Technology |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
DNAX Research, Inc. | |
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Commercial Services |
- Bourse
- Insiders
- Richard Murray
- Expérience